MKM: Motorola may still sell 500,000 Verizon phones in Q2 despite DROID BIONIC delay

MKM Partners analyst Terry Kuittinen on Friday issued a note to investors reiterating a Buy rating on Motorola Mobility stock, setting the firm’s price target at $35. Kuittinen states that Motorola will likely see success with British carrier Orange, which launched Motorola’s new ATRIX smartphone ahead of upcoming competitors like the Samsung Galaxy S II and the LG Optimus 2X. The analyst also noted that the ATRIX is getting strong promotional backing elsewhere from carriers like TIM. In the U.S., Kuittinen thinks the delayed launch of Motorola’s upcoming DROID BIONIC won’t have much of an impact on the company’s sales, considering the higher pricing of 4G LTE phones like the LG Revolution, HTC ThunderBolt and Samsung DROID Charge. Motorola’s upcoming $200 DROID X2 will be a winner at Verizon Wireless, the analyst believes, and it could help Motorola sell 500,000 phones through Verizon this quarter.

Tags: 3G, 4G, Android, DROID Bionic, estimates, evdo, LTE, Motorola, Motorola Mobility, Sales, Shipments, Smartphones, Verizon, verizon wireless, VZW

Zach Epstein